An Update from Numinus – Canada’s preeminent psychedelic company

Payton Nyquvest founded Numinus Wellness after recognizing a gap in the healthcare system. Payton’s lifelong interest in health, wellness, and personal development drives his vision and commitment to psychedelic science. Payton was formerly a Director with Mackie Research Capital and spent 15 years focused on early-stage companies in technology, health-care/biotech, cleantech and Cannabis. He has raised over $100M for 100+ public and private companies and facilitated numerous IPOs.